DECEMBER 22, 2015 Economy News The government might consider pruning the list of around 300 goods exempt from excise duty in the Budget to make up for the extra expenditure on account of higher government salaries and defence pensions in the next financial year. (BS) The Reserve Bank of India (RBI) will soon release a discussion paper on unregulated peer-to-peer lending (P2PL) arrangements, which is lending money to unrelated individuals without assistance from any financial intermediary. (BS) The government introduced the 'Insolvency and Bankruptcy Code 2015', or the bankruptcy Bill, in the Lok Sabha on Monday. The Bill is one of the steps that Finance Minister Arun Jaitley has identified as crucial for India to improve ease of doing business. (BS) Under a new commercial mining plan approved by the Cabinet last week, the Centre is likely to offer six coal blocks to state governments. State governments allotted coal blocks will not be allowed to issue equity or coal-selling rights to private parties. (BS) Corporate News State Bank of India (SBI), has said that its board of directors had authorized the bank to raise up to Rs.120 bn of tier-ii capital through Basel-III compliant bonds by way of private placement. (ET) Real estate developer HDIL has sold 0.85 mn square feet of development rights in Kurla to a company belonging to the Mumbai-based Wadhawan Group for Rs.6.5 bn. (BS) Adani Green Energy, a subsidiary of Adani Enterprises, has acquired 100% equity stake in Ahmedabad-based Duryodhana Developers, Adani Enterprises said in a regulatory statement on stock exchange. (ET) Drug firm Strides Shasun has received approval from the Drug Controller General of India to produce a generic version of Gilead's 'Sovaldi', used for the treatment of hepatitis C. The company has received approval for manufacturing a generic version of Sofosbuvir 400 mg. (BS) RCOM has said that it has sold nearly 150 residential flats in Navi Mumbai for Rs.3.3 bn, the proceeds from which will be used to repay debt. (ET) Drug maker Cipla has announced the launch of a generic version of antihepatitis drug Ledipasvir-Sofosbuvir in the domestic market. The drug is used for treating the hepatitis C virus. Mahindra & Mahindra will commercially launch electric variants of its Verito (pictured) passenger car and Maxximo mini truck by February and is in talks with cab aggregators to boost sales of more environmentalfriendly cars in the country. (BS) Tata Motors, traditionally been dependent on diesel engines, is working on partial hybrids and fully-electric systems for its future range of passenger vehicles. It is also working on a new generation of lesspolluting petrol engines. (BS) Travel major Thomas Cook India has entered into a strategic partnership with digital payment solutions company ItzCash to extend its outreach to India's rapidly growing unbanked inward remittance market, by offering remittance services. (ET) Source: ET = Economic Times, BS = Business Standard, FE = Financial Express, BL = Business Line, LM = Live Mint, ToI: Times of India, BSE = Bombay Stock Exchange Equity % Chg 20 Nov 15 1 Day 1 Mth 3 Mths Indian Indices SENSEX Index 25,736 0.8 (0.5) 0.3 NIFTY Index 7,834 0.9 (0.3) 0.3 BANKEX Index 19,204 1.4 (1.4) (1.5) SPBSITIP Index 11,051 0.9 2.3 (1.6) BSETCG INDEX 14,081 0.4 (3.0) (7.1) BSEOIL INDEX 9,298 0.9 1.5 7.9 CNXMcap Index 13,280 0.8 1.4 3.5 SPBSSIP Index 11,626 0.8 2.3 6.3 World Indices Dow Jones 17,252 0.7 (3.2) 5.6 Nasdaq 4,969 0.9 (2.7) 4.5 FTSE 6,035 (0.3) (4.7) 1.7 NIKKEI 18,916 (0.4) (5.1) 4.4 HANGSENG 21,792 0.2 (4.2) (0.0) Value traded (Rs cr) 20 Nov 15 % Chg - Day Cash BSE 2,372 (20.5) Cash NSE 13,295 (26.0) Derivatives - - Net inflows (Rs cr) 19 Nov 15 % Chg MTD YTD FII 83 (89) (3,015) 15,135 Mutual Fund 72 21 1,486 67,154 FII open interest (Rs cr) 19 Nov 15 % Chg FII Index Futures 14,418 (0.5) FII Index Options 75,192 2.6 FII Stock Futures 52,973 1.3 FII Stock Options 4,214 4.2 Advances / Declines (BSE) 20 Nov 15 A B T Total % total Advances 212 955 87 1,254 66 Declines 82 429 53 564 30 Unchanged 4 55 20 79 4 1,897 100 Commodity % Chg 20 Nov 15 1 Day 1 Mth 3 Mths Crude (US$/BBL) 36.0 0.6 (10.8) (21.4) Gold (US$/OZ) 1,080.6 1.4 (0.1) (4.3) Silver (US$/OZ) 14.3 1.2 0.5 (3.8) Debt / forex market 20 Nov 15 1 Day 1 Mth 3 Mths 10 yr G-Sec yield % 7.8 7.8 7.7 7.7 Re/US$ 66.4 66.4 66.5 65.7 Sensex 30,500 29,500 28,500 27,500 26,500 25,500 24,500 Nov-14 Feb-15 May-15 Aug-15 Nov-15
Amit Agarwal agarwal.amit@kotak.com +91 22 6621 6222 Berger Paints PRICE: RS.238 RECOMMENDATION: BUY TARGET PRICE: RS.275 FY17E PE: 34.1X Stock details BSE code : 509480 NSE code : BERGEPAINT Market cap (Rs bn) : 153.0 Free float (%) : 25.0 52 wk Hi/Lo (Rs) : 252 / 168 Avg daily volume : 276,000 Shares (o/s) (mn) : 69.3 Summary table (Rs mn) FY15 FY16E FY17E Sales 43,273 48,514 56,509 Growth (%) 11.8 12.1 16.5 EBITDA 5,077 6,571 7,962 EBITDA margin (%) 11.7 13.5 14.1 PBT 4,011 5,531 6,817 Net profit 2,848 3,927 4,840 EPS (Rs) 4.1 5.7 7.0 Growth (%) 14.1 37.9 23.2 CEPS (Rs) 5.6 7.2 8.7 BV (Rs/share) 20.0 24.8 30.9 Dividend/share (Rs) 1.0 1.0 1.0 ROE (%) 20.5 22.9 22.6 ROCE (%) 23.0 26.1 26.7 Net cash (debt) (3,210) (2,071) (157) NW Capital (Days) 44.4 51.4 55.3 EV/EBITDA (x) 30.8 24.2 20.1 P/E (x) 57.9 42.0 34.1 P/Cash Earnings 42.4 32.9 27.3 P/BV (x) 11.9 9.6 7.7 Source: Company, Kotak Securities - Private Client Research Shareholding pattern Corporate bodies 4% FIIs 9% Domestic Institutions 3% Source: ACE Equity Public 9% Promoter 75% One-year performance (Rel to Nifty) Berger Paints (Berger) is the second largest decorative paints company in India with ~19% share of organized market and third largest in the industrial segment with 9% share of the organised market. It also has a presence in the overseas markets, prominent ones being Nepal and Poland. We estimate Berger to report strong earnings CAGR of 30% over FY15 to FY17E with its extension into premium products and investment into distribution, yielding returns. Moderation in capex should result in healthy free cash flow generation of ~Rs 4.7 bn over FY15 to FY17E. Further we estimate, gap in ROE between Berger and Asian Paints (APL) to narrow, given Berger's stronger EBIT margin expansion. We expect Berger to re-rate and valuation discount between APL and Berger to reduce. Initiate with BUY and TP of Rs275 (at 39 x FY17 EPS vs. 42 x for APL) Key investment argument Healthy growth in the decorative paint segment. Berger has been adding capacity across segments in decorative paints which has helped the company achieve healthy volume growth in FY15 (at 15%) which we estimate to be ahead of the market. Berger's market share in decorative segment has increased ~100-150bps over the past three years. Management is hopeful of gaining further share driven by strong focus on growing the premium portfolio (currently <20% share), enhancing distribution reach (aims to increase dealer and tinting machine base by 10-12% p.a.) and increasing its presence in South and West regions (traditionally strong in North and East). Prospects to improve in the industrial segment of company s revenues. Berger is a distant third player in the industrial segment with 9% market share having presence across protective coating (where it is a dominant player), automotive paints and powder coatings. With improvement in macro environment, industrial capex and automotive sales, we estimate contribution of industrial segment to overall revenues and profitability to improve for Berger over FY15 to FY17E. Margins to expand/healthy return ratios. Berger has maintained its EBIDTA margins at ~ 11% and ROE at ~21% over FY10 to FY15. With improving macro environment and benign raw material situation, we expect the EBIDTA margins of the company to improve 240 bps over FY15 to FY17E. With improving margins and no major capex, we estimate the ROE of the company to stabilise at ~23%. Valuation and outlook There has been a re-rating of the paint sector in the last 3 to 4 years with all the paint companies trading above their historical average one year forward PE for the last 5 years. The companies also trade at ~30 percent premium to global paint companies, which is justified by the long term prospects of Indian Paint companies. These companies have also rallied by more than 20% in the last six months on expectations of margin expansion following sharp decline in crude oil prices. The stock of Berger at CMP of Rs 238 is trading 34.1x FY17E P/E. We prefer to use a P/E approach to value the stock (like any other consumer company) and give a value of 39x one year forward FY17E P/E which is at ~10% discount to valuation of APL. We believe the multiple is justified on account of improving macros and earnings profile. We initiate coverage on BERGER with a BUY rating and at TP of Rs 275. Source: ACE Equity Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client Group. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Institutional Equities Research Group of Kotak Securities Limited. Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 2
Risks & concerns Weak macro environment leading to poor demand for decorative paints Prolong slowdown in the economy leading to weak capex cycle impacting industrial demand Sharp increase in raw material prices coupled with inability to take price hikes Increasing competition Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 3
Gainers & Losers Nifty Gainers & Losers Price (Rs) chg (%) Index points Volume (mn) Gainers ICICI BANK 258 3.2 (0.0) 13.0 ONGC 230 3.2 (0.0) 3.3 POWER GRID 139 3.0 (0.0) 3.5 Losers SUN PHARMA 754 (4.6) (0.0) 12.3 GAIL INDIA 336 (1.0) (0.0) 0.83 ASIAN PAINTS 874 (0.7) (0.0) 0.90 Source: Bloomberg Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 4
RATING SCALE Definitions of ratings BUY We expect the stock to deliver more than 12% returns over the next 9 months ACCUMULATE We expect the stock to deliver 5% - 12% returns over the next 9 months REDUCE We expect the stock to deliver 0% - 5% returns over the next 9 months SELL We expect the stock to deliver negative returns over the next 9 months NR Not Rated. Kotak Securities is not assigning any rating or price target to the stock. The report has been prepared for information purposes only. RS Rating Suspended. Kotak Securities has suspended the investment rating and price target for this stock, either because there is not a sufficient fundamental basis for determining, or there are legal, regulatory or policy constraints around publishing, an investment rating or target. The previous investment rating and price target, if any, are no longer in effect for this stock and should not be relied upon. NA Not Available or Not Applicable. The information is not available for display or is not applicable NM Not Meaningful. The information is not meaningful and is therefore excluded. NOTE Our target prices are with a 9-month perspective. Returns stated in the rating scale are our internal benchmark. Fundamental Research Team Dipen Shah IT dipen.shah@kotak.com +91 22 6621 6301 Sanjeev Zarbade Capital Goods, Engineering sanjeev.zarbade@kotak.com +91 22 6621 6305 Teena Virmani Construction, Cement teena.virmani@kotak.com +91 22 6621 6302 Saday Sinha Banking, NBFC, Economy saday.sinha@kotak.com +91 22 6621 6312 Arun Agarwal Auto & Auto Ancillary arun.agarwal@kotak.com +91 22 6621 6143 Ruchir Khare Capital Goods, Engineering ruchir.khare@kotak.com +91 22 6621 6448 Ritwik Rai FMCG, Media ritwik.rai@kotak.com +91 22 6621 6310 Sumit Pokharna Oil and Gas sumit.pokharna@kotak.com +91 22 6621 6313 Amit Agarwal Logistics, Transportation agarwal.amit@kotak.com +91 22 6621 6222 Meeta Shetty, CFA Pharmaceuticals meeta.shetty@kotak.com +91 22 6621 6309 Jatin Damania Metals & Mining jatin.damania@kotak.com +91 22 6621 6137 Pankaj Kumar Midcap pankajr.kumar@kotak.com +91 22 6621 6321 Jayesh Kumar Economy kumar.jayesh@kotak.com +91 22 6652 9172 K. Kathirvelu Production k.kathirvelu@kotak.com +91 22 6621 6311 Technical Research Team Shrikant Chouhan shrikant.chouhan@kotak.com +91 22 6621 6360 Amol Athawale amol.athawale@kotak.com +91 20 6620 3350 Derivatives Research Team Sahaj Agrawal sahaj.agrawal@kotak.com +91 79 6607 2231 Rahul Sharma sharma.rahul@kotak.com +91 22 6621 6198 Malay Gandhi malay.gandhi@kotak.com +91 22 6621 6350 Prashanth Lalu prashanth.lalu@kotak.com +91 22 6621 6110 Kotak Securities - Private Client Research Please see the disclaimer on the last page For Private Circulation 5
Disclaimer Kotak Securities Limited established in 1994, is a subsidiary of Kotak Mahindra Bank Limited. Kotak Securities is one of India's largest brokerage and distribution house. Kotak Securities Limited is a corporate trading and clearing member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited (NSE), Metropolitan Stock Exchange of India Limited (MSEI), United Stock Exchange of India Limited (USEIL). Our businesses include stock broking, services rendered in connection with distribution of primary market issues and financial products like mutual funds and fixed deposits, depository services and Portfolio Management. Kotak Securities Limited is also a depository participant with National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL).Kotak Securities Limited is also registered with Insurance Regulatory and Development Authority as Corporate Agent for Kotak Mahindra Old Mutual Life Insurance Limited and is also a Mutual Fund Advisor registered with Association of Mutual Funds in India (AMFI). We are registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014" We hereby declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered in last five years. However SEBI, Exchanges and Depositories have conducted the routine inspection and based on their observations have issued advise letters or levied minor penalty on KSL for certain operational deviations. We have not been debarred from doing business by any Stock Exchange / SEBI or any other authorities; nor has our certificate of registration been cancelled by SEBI at any point of time. We offer our research services to clients as well as our prospects. This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. This material is for the personal information of the authorized recipient, and we are not soliciting any action based upon it. This report is not to be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It is for the general information of clients of Kotak Securities Ltd. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. We have reviewed the report, and in so far as it includes current or historical information, it is believed to be reliable though its accuracy or completeness cannot be guaranteed. Neither Kotak Securities Limited, nor any person connected with it, accepts any liability arising from the use of this document. The recipients of this material should rely on their own investigations and take their own professional advice. Price and value of the investments referred to in this material may go up or down. Past performance is not a guide for future performance. Certain transactions -including those involving futures, options and other derivatives as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. Reports based on technical analysis centers on studying charts of a stock's price movement and trading volume, as opposed to focusing on a company's fundamentals and as such, may not match with a report on a company's fundamentals. Opinions expressed are our current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Kotak Securities Limited has two independent equity research groups: Institutional Equities and Private Client Group. This report has been prepared by the Private Client Group. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, target price of the Institutional Equities Research Group of Kotak Securities Limited. We and our affiliates/associates, officers, directors, and employees, Research Analyst(including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company (ies) discussed herein or act as advisor or lender / borrower to such company (ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of Research Report or at the time of public appearance. Kotak Securities Limited (KSL) may have proprietary long/short position in the above mentioned scrip(s) and therefore may be considered as interested. The views provided herein are general in nature and does not consider risk appetite or investment objective of particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with KSL. Kotak Securities Limited is also a Portfolio Manager. Portfolio Management Team (PMS) takes its investment decisions independent of the PCG research and accordingly PMS may have positions contrary to the PCG research recommendation. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. No part of this material may be duplicated in any form and/or redistributed without Kotak Securities' prior written consent. Details of Associates are available on our website ie www.kotak.com Research Analyst has served as an officer, director or employee of subject company(ies): No We or our associates may have received compensation from the subject company(ies) in the past 12 months. We or our associates may have managed or co-managed public offering of securities for the subject company(ies) in the past 12 months. We or our associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months. We or our associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company(ies) in the past 12 months. We or our associates have not received any compensation or other benefits from the subject company(ies) or third party in connection with the research report. Our associates may have financial interest in the subject company(ies). Research Analyst or his/her relative's financial interest in the subject company(ies): No Kotak Securities Limited has financial interest in the subject company(ies): Yes Our associates may have actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report. Research Analyst or his/her relatives has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No Kotak Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company(ies) at the end of the month immediately preceding the date of publication of Research Report: No Subject company(ies) may have been client during twelve months preceding the date of distribution of the research report. "A graph of daily closing prices of securities is available at www.nseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the "three years" icon in the price chart)." Kotak Securities Limited. Registered Office: 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400051. CIN: U99999MH1994PLC134051, Telephone No.: +22 43360000, Fax No.: +22 67132430. Website: www.kotak.com. Correspondence Address: Infinity IT Park, Bldg. No 21, Opp. Film City Road, A K Vaidya Marg, Malad (East), Mumbai 400097. Telephone No: 42856825. SEBI Registration No: NSE INB/INF/INE 230808130, BSE INB 010808153/INF 011133230, MSEI INE 260808130/ INB 260808135/INF 260808135, AMFI ARN 0164 and PMS INP000000258. NSDL: IN-DP-NSDL-23-97. CDSL: IN-DP-CDSL-158-2001, Research Analyst INH000000586. Our research should not be considered as an advertisement or advice, professional or otherwise. The investor is requested to take into consideration all the risk factors including their financial condition, suitability to risk return profile and the like and take professional advice before investing. Investments in securities are subject to market risk; please read the SEBI prescribed Combined Risk Disclosure Document prior to investing. Derivatives are a sophisticated investment device. The investor is requested to take into consideration all the risk factors before actually trading in derivative contracts.compliance Officer Details: Mr. Manoj Agarwal. Call: 022-4285 6825, or Email: ks.compliance@kotak.com. In case you require any clarification or have any concern, kindly write to us at below email ids: Level 1: For Trading related queries, contact our customer service at 'service.securities@kotak.com' and for demat account related queries contact us at ks.demat@kotak.com or call us on: Online Customers - 30305757 (by using your city STD code as a prefix) or Toll free numbers 18002099191 / 1800222299, Offline Customers - 18002099292 Level 2: If you do not receive a satisfactory response at Level 1 within 3 working days, you may write to us at ks.escalation@kotak.com or call us on 022-42858445 and if you feel you are still unheard, write to our customer service HOD at ks.servicehead@kotak.com or call us on 022-42858208. Level 3: If you still have not received a satisfactory response at Level 2 within 3 working days, you may contact our Compliance Officer (Name: Manoj Agarwal ) at ks.compliance@kotak.com or call on 91- (022) 4285 6825. Level 4: If you have not received a satisfactory response at Level 3 within 7 working days, you may also approach CEO (Mr. Kamlesh Rao) at ceo.ks@kotak.com or Kotak call on Securities 91- (022)- 6652 Private 9160. Client Research Please see the disclaimer on the last page For Private Circulation 6